Fresenius SE & Co. KGaA FRE.DE

Name: FRE.DE quality scores
Creator: Stocktoria
License: https://stocktoria.com/terms/

DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website

Fresenius SE & Co. KGaA (FRE.DE) earns a Piotroski F-score of 7/9 (strong financial health). It pays a dividend yielding 3.04% (safety: moderate). FY2025 revenue was $22.9B at a 5.5% net margin.

7/9

Piotroski F — financial health

—

Altman Z″ — distress risk

54.1%

Dividend payout · moderate

$39.97 as of 2026-06-01 · -6.3% 1y

$36.27$50.9052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap€22.5B

P / E17.8×

Dividend yield3.04%

Net margin5.5%

Return on equity6.6%

Revenue trend · last 4y · up

How it ranks in Healthcare · percentile among 23 companies

Piotroski Fstronger than 52%

Net marginstronger than 27%

Return on equitystronger than 23%

Revenue growthstronger than 39%

Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 7/9 tests passed

Positive return on assets
Positive operating cash flow
Rising ROA
Cash flow exceeds net income
Lower long-term debt
Rising current ratio
No share dilution
Rising gross margin
Rising asset turnover

FAQ

Is FRE.DE financially healthy?

Fresenius SE & Co. KGaA's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak).

Does FRE.DE pay a dividend, and is it safe?

Yes. Fresenius SE & Co. KGaA pays a dividend yielding about 3.04% with a 54.1% payout ratio, rated “moderate” for safety.

How profitable is FRE.DE?

In FY2025, Fresenius SE & Co. KGaA had a net margin of 5.5% and a return on equity of 6.6%.

Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.